Apol­lo makes a deal worth up to $926M; Abeona re­sub­mits gene ther­a­py

Plus, news about Centes­sa, Au­to­lus Ther­a­peu­tics, Zu­cara Ther­a­peu­tics, Vin­dur Tx, Vit­to­ria Bio­ther­a­peu­tics and the MD An­der­son Can­cer Cen­ter:

Apol­lo Ther­a­peu­tics’ car­dio-meta­bol­ic pact: The com­pa­ny will …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER